For example, if CMS grants a likely to be in shortage rebate reduction request for a generic Part D rebatable drug that was submitted on August 15, 2024, and that generic Part D rebatable drug is currently in shortage from September 15, 2025, until May 15, 2026, CMS would apply a 75 percent reduction in the total rebate amount for the duration of the applicable period for which the likely to be in shortage rebate reduction request was granted (that is, October 1, 2024, to September 30, 2025), and then would apply the shortages reduction as proposed in 428.301, beginning with a reduction of 75 percent for a generic Part D rebatable drug for the applicable period beginning October 1, 2025
At NativeSmokes4Less, weve got you covered with smokeless tobacco, classic cigarettes, nicotine pouches, and vapes
It takes, on average, four to seven serious tries to quit successfully long term
Department of Labor's Bureau of Labor Statistics (BLS) publishes the official measures of productivity for the U.S